| The multiple roles of amphiregulin in human cancer B Busser, L Sancey, E Brambilla, JL Coll, A Hurbin Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1816 (2), 119-131, 2011 | 297 | 2011 |
| The Multifaceted Roles of Copper in Cancer: A Trace Metal Element with Dysregulated Metabolism, but also a Target or a Bullet for Therapy P Lelièvre, L Sancey, JL Coll, A Deniaud, B Busser Cancers 12 (12), 3594, 2020 | 243 | 2020 |
| Elemental imaging using laser-induced breakdown spectroscopy: A new and promising approach for biological and medical applications B Busser, S Moncayo, JL Coll, L Sancey, V Motto-Ros Coordination Chemistry Reviews 358, 70-79, 2018 | 174 | 2018 |
| Laser spectrometry for multi-elemental imaging of biological tissues L Sancey, V Motto-Ros, B Busser, S Kotb, JM Benoit, A Piednoir, F Lux, ... Scientific reports 4, 6065, 2014 | 168 | 2014 |
| Laser-induced breakdown spectroscopy for human and animal health: A review R Gaudiuso, N Melikechi, ZA Abdel-Salam, MA Harith, V Palleschi, ... Spectrochimica Acta Part B: Atomic Spectroscopy 152, 123-148, 2019 | 147 | 2019 |
| 3D imaging of nanoparticle distribution in biological tissue by laser-induced breakdown spectroscopy Y Gimenez, B Busser, F Trichard, A Kulesza, JM Laurent, V Zaun, F Lux, ... Scientific reports 6 (1), 29936, 2016 | 123 | 2016 |
| Multi-elemental imaging of paraffin-embedded human samples by laser-induced breakdown spectroscopy S Moncayo, F Trichard, B Busser, M Sabatier-Vincent, F Pelascini, N Pinel, ... Spectrochimica Acta Part B: Atomic Spectroscopy 133, 40-44, 2017 | 79 | 2017 |
| Amphiregulin promotes BAX inhibition and resistance to gefitinib in non-small-cell lung cancers B Busser, L Sancey, V Josserand, C Niang, MC Favrot, JL Coll, A Hurbin Molecular Therapy 18 (3), 528-535, 2010 | 76 | 2010 |
| Water-Soluble Aza-BODIPYs: Biocompatible Organic Dyes for High Contrast In Vivo NIR-II Imaging A Godard, G Kalot, J Pliquett, B Busser, X Le Guével, KD Wegner, ... Bioconjugate Chemistry 31 (4), 1088-1092, 2020 | 73 | 2020 |
| The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase‐dependent mechanism V Jeannot, B Busser, E Brambilla, M Wislez, B Robin, J Cadranel, JL Coll, ... International Journal of Cancer 134 (11), 2560-2571, 2014 | 63 | 2014 |
| Major response to vemurafenib in patient with severe cutaneous Langerhans cell histiocytosis harboring BRAF V600E mutation J Charles, JC Beani, G Fiandrino, B Busser Journal of the American Academy of Dermatology 71 (3), e97-e99, 2014 | 62 | 2014 |
| Insulin‐like growth factor‐1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma A Hurbin, M Wislez, B Busser, M Antoine, C Tenaud, N Rabbe, S Dufort, ... The Journal of pathology 225 (1), 83-95, 2011 | 62 | 2011 |
| Radiation Dose‐Enhancement Is a Potent Radiotherapeutic Effect of Rare‐Earth Composite Nanoscintillators in Preclinical Models of Glioblastoma AL Bulin, M Broekgaarden, F Chaput, V Baisamy, J Garrevoet, B Busser, ... Advanced Science 7 (20), 2001675, 2020 | 60 | 2020 |
| Laser-Induced Breakdown Spectroscopy Imaging for Material and Biomedical Applications: Recent Advances and Future Perspectives V Gardette, V Motto-Ros, C Alvarez-Llamas, L Sancey, L Duponchel, ... Analytical Chemistry 95 (1), 49-69, 2023 | 57 | 2023 |
| Plasma circulating tumor DNA levels for the monitoring of melanoma patients: landscape of available technologies and clinical applications B Busser, J Lupo, L Sancey, S Mouret, P Faure, J Plumas, L Chaperot, ... BioMed Research International 2017 (1), 5986129, 2017 | 56 | 2017 |
| Amphiregulin promotes resistance to gefitinib in nonsmall cell lung cancer cells by regulating Ku70 acetylation B Busser, L Sancey, V Josserand, C Niang, S Khochbin, MC Favrot, ... Molecular Therapy 18 (3), 536-543, 2010 | 55 | 2010 |
| Adequacy of CT-guided biopsies with histomolecular subtyping of pulmonary adenocarcinomas: influence of ATS/ERS/IASLC guidelines GR Ferretti, B Busser, F de Fraipont, E Reymond, A McLeer-Florin, ... Lung Cancer 82 (1), 69-75, 2013 | 50 | 2013 |
| Iron Dysregulation in Human Cancer: Altered Metabolism, Biomarkers for Diagnosis, Prognosis, Monitoring and Rationale for Therapy P Lelièvre, L Sancey, JL Coll, A Deniaud, B Busser Cancers 12 (12), 3524, 2020 | 46 | 2020 |
| Comparison of COBAS 4800 KRAS, TaqMan PCR and High Resolution Melting PCR assays for the detection of KRAS somatic mutations in formalin-fixed paraffin … A Harlé, B Busser, M Rouyer, V Harter, P Genin, A Leroux, JL Merlin Virchows Archiv 462, 329-335, 2013 | 42 | 2013 |
| Aza-BODIPY: A New Vector for Enhanced Theranostic Boron Neutron Capture Therapy Applications G Kalot, A Godard, B Busser, J Pliquett, M Broekgaarden, V Motto-Ros, ... Cells 9 (9), 1953, 2020 | 40 | 2020 |
Lucie SanceyDR CNRS, Institute for Advanced Biosciences Grenoble, FranceBestätigte E-Mail-Adresse bei univ-grenoble-alpes.fr
